Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T F Scott

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
The American Journal of Medicine|October 1, 1990
Primary intracranial meningeal lymphomaT F Scott, E L Hogan, T D Carter, et al.
Journal of the Neurological Sciences|May 1, 2007
Gene expression changes in peripheral blood mononuclear cells from multiple sclerosis patients undergoing beta-interferon therapyM K Singh, T F Scott, W A LaFramboise, et al.
Biomaterials|April 28, 2004
Colonization and maintenance of murine embryonic stem cells on poly(alpha-hydroxy esters)J Harrison, S Pattanawong, J S Forsythe, et al.
Biophysical Chemistry|May 21, 2005
Morphology and gelation of thermosensitive chitosan hydrogelsK E Crompton, R J Prankerd, D M Paganin, et al.
Multiple Sclerosis and Related Disorders|April 17, 2015
The CombiRx trial of combined therapy with interferon and glatiramer acetate in relapsing remitting MS: Design and baseline characteristicsJ W Lindsey, T F Scott, S G Lynch, et al.
Journal of Dental Research|September 7, 2018
Biological and Mechanical Evaluation of Novel Prototype Dental CompositesH L Van der Laan, S L Zajdowicz, K Kuroda, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 23, 2008
Avonex Combination Trial in relapsing--remitting MS: rationale, design and baseline dataJ A Cohen, P A Calabresi, S Chakraborty, et al.
Neurology|February 11, 2009
Results of the Avonex Combination Trial (ACT) in relapsing-remitting MSJ A Cohen, P B Imrey, P A Calabresi, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
The American Journal of Medicine|October 1, 1990
Primary intracranial meningeal lymphomaT F Scott, E L Hogan, T D Carter, et al.
Journal of the Neurological Sciences|May 1, 2007
Gene expression changes in peripheral blood mononuclear cells from multiple sclerosis patients undergoing beta-interferon therapyM K Singh, T F Scott, W A LaFramboise, et al.
Biomaterials|April 28, 2004
Colonization and maintenance of murine embryonic stem cells on poly(alpha-hydroxy esters)J Harrison, S Pattanawong, J S Forsythe, et al.
Biophysical Chemistry|May 21, 2005
Morphology and gelation of thermosensitive chitosan hydrogelsK E Crompton, R J Prankerd, D M Paganin, et al.
Multiple Sclerosis and Related Disorders|April 17, 2015
The CombiRx trial of combined therapy with interferon and glatiramer acetate in relapsing remitting MS: Design and baseline characteristicsJ W Lindsey, T F Scott, S G Lynch, et al.
Journal of Dental Research|September 7, 2018
Biological and Mechanical Evaluation of Novel Prototype Dental CompositesH L Van der Laan, S L Zajdowicz, K Kuroda, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 23, 2008
Avonex Combination Trial in relapsing--remitting MS: rationale, design and baseline dataJ A Cohen, P A Calabresi, S Chakraborty, et al.
Neurology|February 11, 2009
Results of the Avonex Combination Trial (ACT) in relapsing-remitting MSJ A Cohen, P B Imrey, P A Calabresi, et al.
Pageof 5